Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years.
News Sanders calls on FDA to allow low-cost rivals to $375k Catal... US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a
News Marathon halts launch of Duchenne drug after price outcry Company says it will listen to concerns of patient advocates
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
